Alpha Tau Medical Ltd. Warrant

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch DRTSW and buy or sell other stocks, ETFs, and their options commission-free!

About DRTSW

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. 

CEO
Uzi Sofer, MBA
CEOUzi Sofer, MBA
Employees
Employees
Headquarters
Jerusalem, Jerusalem
HeadquartersJerusalem, Jerusalem
Founded
2015
Founded2015
Employees
Employees

DRTSW Key Statistics

Market cap
Market cap
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
10.40K
Average volume10.40K
High today
$0.36
High today$0.36
Low today
$0.35
Low today$0.35
Open price
$0.36
Open price$0.36
Volume
6.60K
Volume6.60K
52 Week high
$0.50
52 Week high$0.50
52 Week low
$0.13
52 Week low$0.13

Stock Snapshot

Alpha Tau Medical Ltd. Warrant(DRTSW) stock is priced at $0.35.

On 2025-12-15, Alpha Tau Medical Ltd. Warrant(DRTSW) stock moved within a range of $0.35 to $0.36. With shares now at $0.35, the stock is trading 0.0% above its intraday low and -2.8% below the session's peak.

Trading activity shows a volume of 6.6K, compared to an average daily volume of 10.4K.

The stock's 52-week range extends from a low of $0.13 to a high of $0.50.

The stock's 52-week range extends from a low of $0.13 to a high of $0.50.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.